64
Research Trials
29
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.

Cough is a ubiquitous health indicator whose global physical, psychological, and financial burden is extremeand underappreciated. As a disruptive, discrete, and information-rich symptom that is associated with a myriadof diseases, cough is also the ideal clinical endpoint. And yet, even in the age of mobile health, AI, and BigData, cough continues to be assessed mainly through subjective surveys and brief acoustic recordings withbulky and expensive clinical devices. Half the world population now carries smartphones that, when combinedwith AI-powered software, can be used as clinical tools for quantifying cough endpoints objectively.
Scalable mobile cough monitoring has the potential to transform clinical trials by increasing their success rate, decimatingtheir costs, accelerating products to market, and improving health equity worldwide.
Bring objective cough data to your study. Schedule a meeting →